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Definition                                           
Chronic Hepatitis 
Chronic hepatitis (CH) is defined as inflammatory disease of the liver 
lasting for more than six months with common causes include hepatitis 
B and C viruses, autoimmune liver disease (autoimmune hepatitis),
steatohepatitis (nonalcoholic steatohepatitis or alcoholic hepatitis), and 
some drugs, characterized by liver enzymes elevation, the presence of 
autoantibodies, elevated gamma globulin and other proteins levels, 
interface hepatitis on histology, and may occur with limited or no 
symptoms, but often leads to yellow discoloration of the skin, mucus 
membranes, and conjunctivae, poor appetite and malaise, with progress 
to fibrosis (scarring) and cirrhosis.
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis
Epidemiology                                           
Chronic Hepatitis 
• Worldwide, viral hepatitis is the most common cause, followed 
closely by alcoholic liver disease and non-alcoholic fatty liver 
disease (NAFLD)
• Chronic hepatitis B is estimated up to 240 million people in the world 
• Chronic hepatitis C is estimated up to 180 million people in the world 
• Other less common causes of hepatitis include autoimmune 
diseases, poisoning especially through toxication, certain medications 
(such as paracetamol), some industrial organic solvents, and plants.
https ://en.wikipedia.org/wiki/Hepatitis#Epidemiology
Epidemiology                                           
Chronic Hepatitis: Hepatitis B Virus Infection
http://www.medsci.org/v02p0050.htm
Epidemiology                                           
Chronic Hepatitis: Hepatitis C Virus Infection
http://www.ourmed.org/images/1/1f/Cdchepctransmission.jpg s-media-cache-ak0.pinimg.com/236x/32/7f/52/327f52a6cce62062ab436675e03dfafe.jpg
Risk Factors                                         
Chronic Hepatitis 
• Infectious agents
• Sex female
• Tattooing history
• Endoscopy, major surgery 
• Phlebotomy, intravenous Drug Use
• High risk job included nurse and barber
• Dentist visit 
• Obesity
• Dyslipidemia
• Glucose intolerance
• Excessive alcohol consumption
• More than 900 drugs, toxins, and herbs
file:///C:/Users/asus/Downloads/JJM_Issue_14,_267-272.pdf
Etiology                                              
Chronic Hepatitis 
• Infectious ((hepatitis B, C, D; parasitic hepatitis; bacterial hepatitis)
• Metabolic (alcoholic hepatitis, toxic and drug-induced hepatitis, non-
alcoholic fatty liver disease)
• Ischemic (due to insufficient blood or oxygen)
• Autoimmune (an abnormal immune response against liver cells, often 
with other autoimmune diseases)
• Genetic ( alpha-1-antitrypsin deficiency, hemochromatosis, Wilson 
disease (autosomal recessive inherited disorder of copper 
metabolism))
• Other
https://en.wikipedia.org/wiki/Hepatitis#Metabolic
Etiology                                              
Chronic Hepatitis: Viruses 
https://en.wikipedia.org/wiki/Viral_hepatitis
HBV HCV HDV
Transmission Parenteral Parenteral Parenteral
Classification Orthohepadnavirus Hepacivirus Deltavirus
Genome dsDNA-RT +ssRNA −ssRNA
Antigens HBsAg,HBeAg Core antigen Delta antigen
Incubation 
period
45–160 days 15–150 days 30–60 days
Severity/Chronici
ty[4]
occasionally 
severe; 5–10% 
chronic
subclinical; 70% 
chronic
exacerbates 
symptoms of 
HBV; chronic w/ 
HBV
Vaccine
3 injections, 
lifetime protection
None available None available
Etiology                                               
Chronic Hepatitis: Hepatitis B Particle Types  
http://www.hepatitisbviruspage.com/hb
• The hepatitis B virion (HBV, the Dane particle) has a diameter around 42nm
• The outer envelope contains high amounts of hepatitis B surface proteins
• The envelope surrounds the inner nucelocapsid which is comprised of 180 hepatitis B 
core proteins arranged in an icosahedral arrangement with T=3 and T=4 symmetry
• The nucleocapsid also contains at least one hepatitis B polymerase protein as well as 
the HBV genome
• Two other subviral particles can be found in an infected individual's serum, namely the 
hepatitis B filament and hepatitis B sphere (a diameter of 22nm) that are composed 
solely of hepatitis B surface proteins without infectious nature.   
Etiology                                               
Chronic Hepatitis: Hepatitis C Particle Types  
http://www.hepatitisbviruspage.com/hb
• The hepatitis C virus (HCV) particle consists of a core of genetic material (RNA), 
surrounded by an icosahedral protective shell of protein, and further encased in a lipid 
(fatty) envelope of cellular origin
• Two viral envelope glycoproteins, E1 and E2, are embedded in the lipid envelope
• The virus replicates mainly in the hepatocytes of the liver, where it is estimated that 
daily each infected cell produces approximately fifty virions with a calculated total of 
one trillion virions generated
• The virus may also replicate in peripheral blood mononuclear cells, potentially 
accounting for the high levels of immunological disorders found in chronically infected 
HCV patients.  
Etiology                                               
Chronic Hepatitis: Hepatitis D Particle Types  
http://www.hepatitisbviruspage.com/hb
• In 1977, an Italian doctor named Mario Rizzetto discovered a new nuclear antigen 
in the liver cells of patients infected with Hepatitis B Virus (HBV)
• The antigen was thought to be a new protein encoded by HBV, and it was labeled 
as the delta antigen
• Subsequent research on chimpanzees, however, indicated that this antigen was 
derived from a new virus, named the Hepatitis Delta Virus (HDV)
• HDV is not classified into a viral family because it is a unique virus dependent on 
HBV. 
Etiology                                               
Chronic Hepatitis 
Hepatitis B transmitted vertically in areas of high incidence (perinatally) 
from mother to baby during birth) or horizontally by being exposed to 
infected blood or blood products or less common through exposure to 
mucous membranes
Hepatitis C  transmitted in same ways and has become the most 
common viral hepatitis since widespread vaccination for Hepatitis B in 
the mid1980s. 
en.wikipedia.org/wiki/Hepatitis 
Mechanisms                                      
Chronic Hepatitis 
• The specific mechanism varies and depends on the underlying cause
• In viral hepatitis, the presence of the virus causes the immune system to 
attack the liver, resulting in inflammation and impaired function
• In autoimmune hepatitis, the immune system attacks the liver due to the 
autoimmune disease
• In some hepatitis, often including hepatitis caused by alcoholism, fat 
deposits accumulate in the liver, resulting in fatty liver disease 
(steatohepatitis)
• Chronic hepatitis in severe cases is occurring  with portal based 
inflammation, fibrosis, disruption of the terminal plate, and piecemeal 
necrosis
• Chronic hepatitis without piecemeal necrosis (formerly called chronic 
persistent hepatitis) has no significant periportal necrosis or regeneration 
with a fairly dense mononuclear portal infiltrate. 
en.wikipedia.org/wiki/Hepatitis
Mechanisms                                      
Chronic Hepatitis: NK Cell-mediated Lysis  
http://www.diapedia.org/img_cache/markdown_lightbox_e0b0ff34f8a4890e9e50cc52cd13677635908c1c-239fe.jpg
NK cell-mediated lysis of intrahepatic cells involved in the pathogenesis 
of viral hepatitis.
Mechanisms                                      
Chronic Hepatitis: Fueling Fibrosis
en.wikipedia.org/wiki/Hepatitis 
Classification 
International Classification of Diseases  
https ://www.tsoshop.co.uk/productimages/default.aspx?ISBN=9789241549165&FORMAT=3  http://apps.who.int/classifications/icd10/browse/2016/en#/XI
XI Diseases of the digestive
B18 Chronic viral hepatitis
K70 Alcoholic liver disease
K71 Toxic liver disease
K73 Chronic hepatitis, not elsewhere 
classified
K74 Fibrosis and cirrhosis of liver
K75 Other inflammatory liver diseases
Classification 
Chronic Hepatitis  
Cases of CH were once classified histologically as chronic 
persistent, chronic lobular, or chronic active hepatitis
A more useful recent classification system specifies the 
following:
• Etiology
• Intensity of histologic inflammation and necrosis 
(grade)
• Degree of histologic fibrosis (stage)
• Inflammation and necrosis are potentially reversible; 
fibrosis usually is not.
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis
Signs and Symptoms                                      
Chronic Hepatitis 1
• About 1/3 of cases develop after acute hepatitis, but most develop 
insidiously de novo 
• Many patients are asymptomatic, especially in chronic HCV infection
• Malaise, anorexia, and fatigue are common, sometimes with low-
grade fever and nonspecific upper abdominal discomfort
• Often, particularly with HCV, the first findings are signs of chronic 
liver disease and cirrhosis (e.g., splenomegaly, spider nevi, palmar 
erythema, portal hypertension, ascites, encephalopathy)
• A few patients develop manifestations of cholestasis (e.g., jaundice, 
pruritus, pale stools, steatorrhea) 
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis
Signs and Symptoms                                      
Chronic Hepatitis 2
• In autoimmune hepatitis, especially in young women, manifestations 
may involve virtually any body system and can include acne, 
amenorrhea, arthralgia, ulcerative colitis, pulmonary fibrosis, 
thyroiditis, nephritis, and hemolytic anemia 
• Chronic HCV is occasionally associated with lichen planus, 
mucocutaneous vasculitis, glomerulonephritis, porphyria cutanea 
tarda, and, perhaps, non-Hodgkin B-cell lymphoma 
• About 1% of patients develop symptomatic cryoglobulinemia with 
fatigue, myalgias, arthralgias, neuropathy, glomerulonephritis, and 
rashes (urticaria, purpura, leukocytoclastic vasculitis); asymptomatic 
cryoglobulinemia is more common.
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis
Clinical Investigation                                                  
Chronic Hepatitis 
• CH is commonly identified on blood tests performed either for 
screening or to evaluate nonspecific symptoms
• The presence of jaundice indicates advanced liver damage
• On physical examination there may be enlargement of the liver
• Extensive damage leads to weight loss, easy bruising and bleeding, 
peripheral edema (swelling of the legs), and accumulation of ascites
• Acne, abnormal menstruation, lung scarring, and inflammation of the 
thyroid gland and kidneys may be present in women with 
autoimmune hepatitis
• CH associated aplastic anemia may occur 2–3 months after an acute 
attack
• Superinfection and coinfection with HDV results in more severe 
complications compared to infection with HBV alone. 
en.wikipedia.org/wiki/Hepatitis 
Clinical Investigation                                                  
Chronic Hepatitis: Alcoholic 
• Alcoholic CH characterized by a myriad of symptoms (feeling unwell, 
enlargement of the liver, ascites, and modest elevation of liver 
enzyme levels
• Alcoholic CH can vary from mild with only liver enzyme elevation to 
severe liver inflammation with development of jaundice, prolonged 
prothrombin time, and even liver failure
• Severe cases are characterized by either dulled consciousness or the 
combination of elevated bilirubin levels and prolonged prothrombin 
time; the mortality rate in both severe categories is 50%
• Alcoholic CH is distinct from cirrhosis caused by long-term alcohol 
consumption.    
• Neuropsychiatric features: asymmetric tremor, personality changes, 
dystonia, spasticity, rigidity, emotional lability, impulsiveness, etc.
en.wikipedia.org/wiki/Hepatitis 
Clinical Investigation                                                  
Chronic Hepatitis: Autoimmune  
• Individuals with autoimmune CH often have no initial symptoms and 
the disease is detected by abnormal liver function tests
• Common initial symptoms include fatigue or muscle aches or signs of 
acute liver inflammation including fever, jaundice, and right upper 
quadrant abdominal pain, and occasionally systemic symptoms such 
as arthralgias, myalgias, polyserositis and thrombocytopenia
• Patients usually present with evidence of moderate to severe 
hepatitis with elevated serum ALT and AST activities in the setting of 
normal to marginally elevated alkaline phosphatase and 
gammaglutamyltranspeptidase activities
• The disease may occur in any ethnic group and at any age, but is most 
often diagnosed in patients between age 40 and 50
• There is a strong female predominance.
en.wikipedia.org/wiki/Hepatitis 
Clinical Investigation                                                  
Chronic Hepatitis: Wilson Disease   
• The major patterns of hepatic involvement: active CH, cirrhosis and 
fulminant hepatic failure
• Neuropsychiatric features: asymmetric tremor, excessive salivation, 
ataxia, masklike facies, clumsiness with the hands, personality 
changes, dystonia, seizures, rigidity, emotional lability, etc.
• Musculoskeletal manifestations: osteoarthritis, osteoporosis, 
osteomalacia, rickets, spontaneous fractures
• Hematologic and renal manifestations: intravascular hemolysis, 
urolithiasis, hematuria
• Kayser-Fleischer rings: the deposition of copper in the Descemet 
membrane in the limbus of the cornea
• Skin pigmentation and a bluish discoloration at the base of the 
fingernails (azure lunulae). 
en.wikipedia.org/wiki/Hepatitis 
Clinical Investigation                                                  
Chronic Hepatitis: Wilson Disease   
Kayser-Fleischer rings.           
http://plasticsurgerykey.com/wp-content/uploads/2016/06/m_gold8_c150f006.png webeye.ophth.uiowa.edu/eyeforum/cases-i/case97/97-1a-lrg.jpg
Skin pigmentation and a bluish 
discoloration at the base of the 
fingernails (azure lunulae). 
Clinical Investigation                                                  
The natural history of chronic hepatitis B 
Stage 1: high viral loads and immune tolerance; in acute infection, this 
corresponds to the incubation period, but with neonatal chronic 
infection, this period often lasts for decades
Stage 2: an immunologic response develops leading to hepatocyte 
necrosis; may persist for 10-20 years and lead to cirrhosis
Stage 3: the immune response decreases the number of infected cells; 
HBeAg is no longer detectable, a marked decrease in HBV viral load is 
observed, and aminotransferase levels become normal; some patients 
continue to have high levels of serum HBV DNA and amino-transferases 
(referred to as HBeAg-negative chronic hepatitis)
Stage 4: patients become negative for HBeAg and positive for anti-HBs, 
and HBV DNA is usually no longer detectable in serum; patients with 
active HBV replication are at increased risk for cirrhosis, hepatic 
decompensation and hepatocellular carcinoma. 
journalofclinicalvirology.com/article/S1386-6532(05)80024-1/abstract 
Clinical Investigation                                                  
Chronic Hepatitis: Activity
Grade 0: no significant inflammation or necrosis
Grade 1 (minimal activity): portal inflammation with predominantly 
mononuclear cells almost entirely confined to the portal areas, no 
interface hepatitis or lobular inflammatory foci
Grade 2 (mild activity): mild portal inflammation, interface hepatitis, 
and scant lobular spotty necrosis
Grade 3 (moderate activity): moderate portal inflammation, interface 
hepatitis, and lobular spotty necrosis
Grade 4 (severe activity): marked portal inflammation, interface 
hepatitis, and lobular necrosis, including bridging necrosis. 
http://emedicine.medscape.com/article/1610728-overview#a6
Clinical Investigation                                                  
Chronic Hepatitis: Fibrosis
Stage 0: no fibrosis 
Stage 1: fibrous portal expansion 
Stage 2: periportal fibrous extension 
Stage 3: fibrous septa formation, including portal-to-central bridging 
fibrosis 
Stage 4: cirrhosis. 
http://emedicine.medscape.com/article/1610728-overview#a6
Complications                                                 
Chronic Hepatitis 
http://www.nhs.uk/Conditions/Hepatitis-B/Pages/Complications.aspx
1  Fibrosis
2  Cirrhosis of the Liver
3  Cancer of the Liver
4 Liver Failure
5 5  Glomerulonephritis
6 6  Cryoglobulinemia
7 7  Hepatic Encephalopathy
8 8  Portal Hypertension
9 9  Porphyria
10 10  Viral Co-Infection 
Diagnosis                                             
Chronic Hepatitis  
• Diagnosis is made by assessing an individual's symptoms, physical 
exam, and medical history, in conjunction with blood tests, liver 
biopsy, and imaging
• Blood testing includes blood chemistry, liver enzymes, serology and 
nucleic acid testing
• Abnormalities in blood chemistry and enzyme results may be 
indicative of certain causes or stages of hepatitis
• Imaging can identify steatosis of the liver but liver biopsy is required 
to demonstrate fibrosis and cirrhosis
• A biopsy is unnecessary if the clinical, laboratory, and radiologic data 
suggests hepatitis. 
en.wikipedia.org/wiki/Hepatitis 
Diagnosis                                             
Chronic Hepatitis: Special Blood  Testing 1 
• Hepatitis B: surface antigen (HBsAg), hepatitis B core antigen 
(HBcAg),  IgM antibodies specific to the hepatitis B core antigen (anti-
HBc IgM), hepatitis B e (a viral protein that is secreted by hepatitis B 
infected cells) antigen (HBeAg); the presence of HBeAg in a host's 
serum is associated with much higher rates of viral replication and 
enhanced infectivity; however, variants of the hepatitis B virus do not 
produce the 'e' antigen, so this rule does not always hold true
• Hepatitis C: HCV antibody enzyme immunoassay or ELISA, 
recombinant immunoblot assay, and quantitative HCV 
RNApolymerase chain reaction (PCR); HCV RNA can be detected by 
PCR typically one to two weeks after infection, while antibodies can 
take substantially longer to form and thus be detected 
en.wikipedia.org/wiki/Hepatitis_C en.wikipedia.org/wiki/Hepatitis 
Diagnosis                                             
Chronic Hepatitis: Special Blood  Testing 2
• Hepatitis D: HDAg in two forms; a large (L)-HDAg, and a small (S)-
HDAg of 24kDa. HDAg-S is produced in the early stages of an infection 
and enters the nucleus and supports viral replication. HDAg-L, in 
contrast, is produced during the later stages of an infection, acts as 
an inhibitor of viral replication, and is required for assembly of viral 
particles. • Autoimmune hepatitis: antinuclear antibody (ANA), anti-
smooth muscle antibody (SMA), liver/kidney microsomal antibody 
(LKM-1, LKM-2, LKM-3), anti soluble liver antigen and liver–pancreas 
antigen (SLA/LP) and anti-mitochondrial antibody (AMA)), increased 
Immunoglobulin G level. The diagnosis always requires a liver biopsy 
en.wikipedia.org/wiki/Hepatitis_C en.wikipedia.org/wiki/Hepatitis 
Diagnosis                                             
Chronic Hepatitis B: Typical Serological Course  
http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/hepatology/hepatitis-b/images/hep-b-fig2.jpg
Diagnosis                                             
Chronic Hepatitis B: Liver Chemistry Test 
en.wikipedia.org/wiki/Hepatitis 
Liver chemistry test Clinical implication of abnormality
Alanine transaminase
Aspartate transaminase Hepatocellular damage
Lactate dehydrogenase
Bilirubin
Alkaline phosphatase
Gamma-glutamyl transpeptidase Cholestasis
Bile acids
Prothrombin time Impaired synthetic function
Albumin
Diagnosis                                             
Chronic Hepatitis: Imaging Studies  
https://www.spandidos-publications.com/10.3892/etm.2011.255
Magnetic resonance 
images in a 51-year-old 
woman with chronic 
hepatitis (A and B) and a 
65-year-old woman with 
liver cirrhosis (C and D). 
Diagnosis                           
Chronic Hepatitis: Biopsy
http://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis
• Unlike in acute hepatitis, biopsy is necessary 
• Mild cases may have only minor hepatocellular necrosis and 
inflammatory cell infiltration, usually in portal regions 
• In more severe cases, biopsy shows periportal necrosis with 
mononuclear cell infiltrates accompanied by variable periportal 
fibrosis and bile duct proliferation 
• In most cases, the specific cause of chronic hepatitis cannot be 
discerned via biopsy alone, although cases caused by HBV can be 
distinguished by the presence of ground-glass hepatocytes and 
special stains for HBV components
• Autoimmune cases have a more pronounced infiltration by 
lymphocytes and plasma cells. 
Diagnosis                                             
Chronic Hepatitis: Histopathologic Features 
https://www.pathology.med.umich.edu/greensonlab/severechronhep.jpg
Severe Chronic Viral Hepatitis.
Diagnosis                                             
Chronic Hepatitis: Wilson Disease 
emedicine.medscape.com/article/183456-overview 
• Serum ceruloplasmin levels are less than 20 mg/dL (reference range, 20-40 mg/dL) 
in approximately 90% of all patients
• The urinary copper excretion rate is greater than 100 mcg/day (reference range, < 
40 mcg/day) in most patients
• In a patient with Kayser-Fleischer rings, a serum ceruloplasmin level < 0 mg/dL and 
24-hoyr urine copper excretion >40 mcg/day establish the diagnosis
• Hepatic copper concentration (criterion standard) on a liver biopsy specimen is 
>250 mcg/g of dry weight even in asymptomatic patients
• Radiolabeled copper testing directly assays hepatic copper metabolism
• Genetic testing is limited to screening of family members for an identified mutation 
detected in the index patient
• Brain imaging shows characteristic findings; MRI appears to be more sensitive than 
CT in detecting early lesions
• Resting ECG abnormalities include left ventricular or biventricular hypertrophy, 
early repolarization, ST segment depression, T-wave inversion, and various 
arrhythmias. 
Diagnosis                                             
Chronic Hepatitis: Wilson Disease’ Histopathologic Features
http://pathologyoutlines.com/caseofweek/case388image10Rhodanine.jpg
Rhodamine stain for copper.
Management                                             
Chronic Hepatitis: Lifestyle Modifications
• Lifestyle modifications are strongly recommended for patients with 
chronic hepatitis
• Even when efficacious pharmacologic interventions are identified, 
lifestyle changes will likely represent an adjuvant treatment because 
new drugs are inevitably expensive and may have unanticipated 
adverse effects after prolonged use
• Lifestyle modifications typically encompass both dietary intervention 
and physical activity goals.  
ncbi.nlm.nih.gov/pmc/articles/PMC3127780/ 
Management                                             
Chronic Hepatitis: Hepatitis B, D 
• Patients with persistently elevated serum alanine aminotransferase, 
and HBV DNA levels are candidates for therapy
• Treatment lasts from six months to a year, depending on medication 
and genotype
• Although none of the available drugs can clear the infection, they can 
stop the virus from replicating, thus minimizing liver damage
• There are seven medications licensed for treatment of hepatitis 
(lamivudine, adefovir, tenofovir, telbivudine, entecavir, interferon 
alpha2a and PEGylated interferon alpha-2a)
• Interferon treatment may produce an e antigen seroconversion rate 
of 37% in genotype A but only a 6% seroconversion in type D
• The drug myrcludex B, which inhibits virus entry into hepatocytes, is 
in clinical trials as of October 2015. 
en.wikipedia.org/wiki/Myrcludex_Ben.wikipedia.org/wiki/Hepatitis_B
Management                                             
Chronic Hepatitis: Hepatitis C 
• HCV induces chronic infection in 50–80% of infected persons
• Approximately 40–80% of these clear with treatment
• In rare cases, infection can clear without treatment
• Those with chronic hepatitis C are advised to avoid alcohol and 
medications toxic to the liver, and to be vaccinated for hepatitis A and 
hepatitis B
• Ultrasound surveillance for hepatocellular carcinoma is 
recommended in those with accompanying cirrhosis. 
en.wikipedia.org/wiki/Hepatitis_C
Management                                             
Chronic Hepatitis: Alcoholic Hepatitis 
• Clinical practice guidelines by the American College of 
Gastroenterology have recommended corticosteroid treatment with 
prednisolone 40 mg daily for four weeks followed by a taper. 
Prednisolone gave a small reduction in mortality at 28 days but this 
did not reach significance, and there were no improvements in 
outcomes at 90 days or 1 year 
• Pentoxifylline (a xanthine derivative) is used to improve blood flow  
for 4 weeks to prevent one patient from dying. Pentoxifylline did not 
improve survival alone or in combination. 
https://en.wikipedia.org/wiki/Alcoholic_hepatitis 
Management                                             
Chronic Hepatitis: Autoimmune Hepatitis  
• Treatment may involve the prescription of immunosuppressive 
glucocorticoids, with or without azathioprine, and remission can be 
achieved in up to 60–80% of cases, although many will eventually 
experience a relapse
• Budesonide has been shown to be more effective in inducing 
remission than prednisone, and result in fewer adverse effects
• Patients who do not respond to glucocorticoids and azathioprine may 
be given other immunosuppressives like mycophenolate, cyclosporin, 
tacrolimus,methotrexate, etc. 
• Liver transplantation may be required if patients do not respond to 
drug therapy or when patients present with fulminant liver failure.
https://en.wikipedia.org/wiki/Autoimmune_hepatitis
Management                                             
Chronic Hepatitis: Wilson Disease  
• The mainstay of therapy is lifelong use of chelating agents (e.g., 
penicillamine, trientine)
• Symptoms, particularly neurologic ones, may worsen with initiation 
of chelation
• Surgical decompression or transjugular intrahepatic shunting (TIPS) is 
reserved for recurrent or uncontrolled variceal bleeding unresponsive 
to standard conservative measures
• Orthotopic liver transplantation is curative
• Other treatments (anticholinergics, baclofen, GABA antagonists, 
levodopa, antiepileptics, neuroleptics )
• Protein restriction, lactulose, or both to treat hepatic.
emedicine.medscape.com/article/183456-overview 
Prognosis 
Chronic Hepatitis 
• Prognosis depends heavily on the disease or condition that is causing 
the symptoms
• Chronic damage to the liver can result in the formation of scar tissue 
(fibrosis) and can result in nodules that block the liver from 
functioning properly (cirrhosis)
• Another complication of chronic hepatitis is liver cancer, specifically 
hepatocellular carcinoma
• Some cases can require a liver transplant. 
en.wikipedia.org/wiki/Hepatitis 
Prophylaxis 
Chronic Hepatitis 1 
• Vaccines are available to prevent hepatitis B
• Vaccines to prevent hepatitis B have been available since 1986 and 
have been incorporated into at least 177 national immunization 
programs for children
• Immunity is achieved in greater than 95% of children and young 
adults receiving the three-dose recombinant virus vaccine
• Vaccination within 24 hours of birth can prevent transmission from an 
infected mother
• Adults over 40 years of age have decreased immune response to the 
vaccine
• The vaccine for hepatitis B protects against hepatitis D virus because 
of the latter's dependence on the presence of hepatitis B virus for it 
to replicate.  
•
en.wikipedia.org/wiki/Hepatitis 
Abbreviations 
CH - Chronic hepatitis
NAFLD - non-alcoholic fatty liver disease
Diagnostic and treatment guidelines
Chronic Hepatitis
Overview of Chronic Hepatitis
AASLD Guidelines for Treatment of Chronic Hepatitis B
Hepatitis B Treatment & Management
Asian-Pacific clinical practice guidelines on the management of hepatitis 
B: a 2015 update
Management of Chronic Hepatitis B: An Overview of Practice Guidelines 
for Primary Care Providers
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